ストックスクリーナーアプリを入手
29.28
1.25%
-0.37
アフターアワーズ：
29.28
前日終値:
$29.65
開ける：
$30
24時間の取引高:
821.75K
Relative Volume:
0.68
時価総額：
$2.41B
収益：
-
当期純損益:
$-154.65M
株価収益率:
-12.31
EPS:
-2.3786
ネットキャッシュフロー:
$-142.43M
1週間 パフォーマンス:
+13.09%
1か月 パフォーマンス:
+8.57%
6か月 パフォーマンス:
-26.15%
1年 パフォーマンス:
+87.33%
1日の値動き範囲:
$28.47
$30.86
1週間の範囲:
$25.16
$30.86
52週間の値動き範囲:
$12.59
$47.65
Mineralys Therapeutics Inc Stock (MLYS) Company Profile
名前
Mineralys Therapeutics Inc
セクター
電話
(888) 378-6240
住所
150 N. RADNOR CHESTER RD., RADNOR
Compare MLYS vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MLYS
Mineralys Therapeutics Inc
|
29.28 | 2.44B | 0 | -154.65M | -142.43M | -2.3786 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 109.34B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 74.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 50.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 39.78B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.02B | 5.36B | 287.73M | 924.18M | 2.5229 |
Mineralys Therapeutics Inc Stock (MLYS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-27 | 開始されました | TD Cowen | Buy |
| 2025-06-11 | 開始されました | Jefferies | Hold |
| 2024-07-10 | 開始されました | H.C. Wainwright | Buy |
| 2024-04-02 | 開始されました | Goldman | Buy |
| 2023-03-07 | 開始されました | BofA Securities | Buy |
| 2023-03-07 | 開始されました | Credit Suisse | Outperform |
| 2023-03-07 | 開始されました | Evercore ISI | Outperform |
| 2023-03-07 | 開始されました | Guggenheim | Buy |
| 2023-03-07 | 開始されました | Stifel | Buy |
| 2023-03-07 | 開始されました | Wells Fargo | Overweight |
すべてを表示
Mineralys Therapeutics Inc (MLYS) 最新ニュース
Mineralys Therapeutics reports inducement awards under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Two new Mineralys hires get stock options and RSUs under Nasdaq rule - Stock Titan
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Mineralys to Report First-Quarter Results on May 6 - MyChesCo
Mineralys Therapeutics Advances Drug Commercialization Through Comprehensive Contract Support - Faegre Drinker
Mineralys fireside chat at Bank of America conference streams May 12 - Stock Titan
Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference - marketscreener.com
Is Mineralys Therapeutics, Inc. (MLYS) A Good Stock To Buy Now? - Insider Monkey
(MLYS) Volatility Zones as Tactical Triggers - Stock Traders Daily
Mineralys Therapeutics (MLYS) Projected to Post Earnings on Wednesday - MarketBeat
Mineralys Therapeutics (NASDAQ:MLYS) Trading 8.2% HigherShould You Buy? - MarketBeat
Why Mineralys Therapeutics Stock Is Surging Today - TipRanks
Mineralys Therapeutics, Inc. $MLYS Shares Bought by Jennison Associates LLC - MarketBeat
Pictet Asset Management Holding SA Sells 76,286 Shares of Mineralys Therapeutics, Inc. $MLYS - MarketBeat
Mineralys Therapeutics to Announce First Quarter 2026 Financial Results and Host Conference Call on Wednesday, May 6, 2026 - Yahoo Finance
Mineralys Therapeutics (NASDAQ:MLYS) Shares Gap DownHere's Why - MarketBeat
TD Cowen initiates coverage of Mineralys Therapeutics (MLYS) with buy recommendation - MSN
Mineralys Therapeutics stock initiated at buy by TD Cowen on drug potential - Investing.com Nigeria
TD Cowen Initiates Mineralys Therapeutics(MLYS.US) With Buy Rating - Moomoo
Mineralys Therapeutics (MLYS) Appoints Jeffrey A. Munsie as Chief Legal Officer - Insider Monkey
10 Best New Stocks to Invest In According to Hedge Funds - Insider Monkey
MLYS Price Today: Mineralys Therapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Price-Driven Insight from (MLYS) for Rule-Based Strategy - Stock Traders Daily
Mineralys Therapeutics CMO Rodman sells $13,033 after option exercise By Investing.com - Investing.com Australia
David Malcom Rodman Sells 416 Shares of Mineralys Therapeutics (NASDAQ:MLYS) Stock - MarketBeat
Mineralys Therapeutics CMO Rodman sells $13,033 after option exercise - Investing.com
Mineralys (MLYS) CMO logs small 10b5-1 share sale and option exercise - Stock Titan
Why Mineralys Therapeutics Shares Are Sliding Now - TipRanks
Mineralys Therapeutics (MLYS) Stock Underperform Rating (Modest Decline) 2026-04-20Price Action - Xã Thanh Hà
Mineralys Therapeutics (MLYS) Stock: Why Pricing Increase (Idled) 2026-04-18Expert Insights - Xã Vĩnh Công
416-share cashless exercise reported by Mineralys (NASDAQ: MLYS) - Stock Titan
David Malcom Rodman Sells 14,058 Shares of Mineralys Therapeutics (NASDAQ:MLYS) Stock - MarketBeat
Mineralys (MLYS) CMO exercises options and sells 20,406 shares in 10b5-1 trades - Stock Titan
Mineralys CEO sells 15,730 shares under 10b5-1 plan | MLYS Insider Trading - Stock Titan
Congleton, Mineralys Therapeutics CEO, sells $421k in MLYS stock By Investing.com - Investing.com Canada
Mineralys Therapeutics (MLYS) CMO Rodman sold $548k in shares By Investing.com - Investing.com Canada
MLYS Stock Climbs As FDA Review And New CLO Draw Trader Focus - timothysykes.com
David Rodman sells shares; Mineralys Therapeutics (NASDAQ: MLYS) Form 144 listing - Stock Titan
Mineralys Therapeutics (NASDAQ:MLYS) Shares Up 10.5%Still a Buy? - MarketBeat
Mineralys therapeutics MLYS: Chief medical officer sells $59k in shares By Investing.com - Investing.com South Africa
Mineralys therapeutics MLYS: Chief medical officer sells $59k in shares - Investing.com India
Mineralys Therapeutics (NASDAQ:MLYS) Insider David Malcom Rodman Sells 2,170 Shares - MarketBeat
Mineralys (MLYS) CMO exercises options and sells 2,170 shares under 10b5-1 plan - Stock Titan
Mineralys Therapeutics (NASDAQ: MLYS) insider sales and RSU vesting disclosed - Stock Titan
Affiliate sale of 14,058 shares and multiple David Rodman trades (MLYS) - Stock Titan
(MLYS) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Sentiment Recap: Whats the profit margin of Mineralys Therapeutics Inc2026 Key Highlights & Daily Profit Maximizing Tips - baoquankhu1.vn
[ARS] Mineralys Therapeutics, Inc. SEC Filing - Stock Titan
Aug Catalysts: What is Mineralys Therapeutics Incs revenue forecastQuarterly Portfolio Summary & Daily Oversold Bounce Ideas - baoquankhu1.vn
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Retail Trends: What are the future prospects of Mineralys Therapeutics Inc2026 Sentiment & Community Shared Stock Ideas - baoquankhu1.vn
Mineralys Therapeutics Inc (MLYS) 財務データ
収益
当期純利益
現金流量
EPS
0.14%
0.48%
大文字化:
|
ボリューム (24 時間):